Reclassifying Cannabis as Schedule III: Unpacking the Impact on Taxation, Medical Research, and Social Justice

Source: JD Supra On April 30, 2024, the Associated Press reported a significant development in cannabis policy:  the U.S. Drug Enforcement Administration (“DEA”) is recommending reclassifying cannabis from Schedule I to Schedule III. This move, spurred by recommendations from the U.S. Department of Health and Human Services (“HHS”) and President Biden’s directive, acknowledges cannabis’ medical benefits and […]